Levitra has been known to cause minor side effects such as dizziness, flushing, headaches, heartburn and upset stomach. However, some people have reported experiencing the far more serious problem of vision loss after taking the medication. This is obviously upsetting for patients who had not been warned that this was a potential side effect of the drug.
Dalli & Marino nursing home abuse attorneys sought treatment from a physician for excessive nighttime urination and periodic erectile dysfunction. The doctor prescribed Levitra for the man Feb. 15, 2010. The following day, the patient was surprised and terrified to learn that he had suffered total vision loss in both eyes after ingesting the medication.
Prior to losing his vision, the patient was a licensed attorney who practiced in Louisiana. After losing his vision, he has been unable to practice law.
The man and his wife have filed a lawsuit against the company that manufactures the drug, Bayer AG, Glaxosmithkline PLC, Merck & Co. f/k/a Schering-Plough Corp., and the doctor who prescribed the medication in the Jefferson Parish District Court. The case was removed to the federal court in New Orleans in mid-March of this year.
In the complaint, the plaintiffs argued that the physician was negligent for prescribing this particular drug when he knew the patient had a history of high blood pressure, high cholesterol and elevated blood sugar. The drug manufacturer, they said, failed to warn consumers of the risk of vision loss or impairment. The medication is defective and unreasonably dangerous as a result of design defects and insufficient testing, they asserted.
The plaintiffs are pursuing damages for physical pain and suffering, mental anguish, fear, worry, concern, emotional distress, loss of enjoyment of life, loss of consortium, medical expenses, interest, court costs and economic losses, including the loss of the ability to engage in the man’s trained profession. They are also seeking punitive damages with the help of top medical malpractice lawyers in Philadelphia.